Skip to main content

Closed

NXGL: NEXGEL, Inc. Stock Analysis | finqOS

Healthcare · Medical - Instruments & Supplies

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+31.5% / yr

Operating margin-31.4%

ROIC-40.3%

Financially safe

Strong

Debt / equity1.07×

Interest coverage185.9×

Current ratio1.70×

NEXGEL, Inc.

NXGLNASDAQ Capital Market·USD·Closed

NEXGEL, Inc.

NXGLNASDAQ·USD·Closed

$0.42

−6.47%

$0.42

−$0.03 (6.47%)

52W Range

0thpctl

Volume

0.25×avg

Mkt Cap

3.83MUSD

P/E

-1.0TTM

Div Yield

–ann

52W Range

0thpctl

Volume

0.25×avg

Market Cap

3.83MUSD

P/E Ratio

-1.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings